From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest News

GoldfishShark

Video: Could We See a Precious Metals Buying Mania?

Trader David Brady is another gold bull whispering sweet nothings into the ear of our own Nigel Somerville.
BMV
premium content

Bluebird Merchant Ventures – good news from the Philippines and news from South Korea set to follow, Buy

Bluebird Merchant Ventures (BMV) states that it is delighted to announce that it has signed an agreement with a Philippine company, whose owners have decades of experience in mining, to develop the high grade Batangas gold project in the Philippines.
AVO
premium content

Advanced Oncotherapy: It Is Surely In Real Trouble Now, the Fat Lady awaits

It seems that no amount of ramping can help AIM-listed Advanced Oncotherapy (AVO) now. The company is in deep shit – and has essentially admitted as much. I would suggest also that the recent note from pay-as-you-go “researcher” (to be polite) Hardman is also an almighty sell signal. At the root of the problem is the cash-guzzling nature of the business, but with a 25p par price and the shares now at just 7.5p it is clear that shareholders are about to take a bath. Or the whole shooting match could follow fellow proton therapy outfit Rutherford Health (RUTH - ex-of the Aquis lobster pot) to the great central bank in the sky. Anyone holding is, in my view, insane.
GetAFix

Follow in the Footsteps of Giants and Don't Trouble the Minnows as Blighty Faces Bleakness.

Hello Share Chums. This old punter is of the belief the recent all-time high for the Footsie will keep going for longer. Therefore, staying in cash is now consigned to my recent history. However, I’m only considering the big 100 index here. The fate of lower value companies is not as encouraging.
ACC

Access Intelligence – how “delighted” to be about recent contract wins?

Describing itself as a “technology innovator delivering Software-as-a-Service solutions for the global marketing and communications industries”, Access Intelligence (ACC) states that it “is pleased to announce a number of contract wins across the globe in the last two months”. So what about these and a current over 3% higher share price response to 79p?
Bearcast
premium content

Tom Winnifrith Bearcast: a buy idea with 20% total return target + what would Ben Turney v1 make of Ben Turney v2 after Friday's nonsense?

In today's podcast I look at Afentra (AET) and Gary Newman's patience with obvious cretins, ScotGold (SGZ), Chill Brands (CHLL), Guild ESports (GILD), Genedrive (GDR) - a £62 million short - Kavango Resources (KAV) and BAT Industries (BATS).
GoldfishShark

Video: The Best Gold Bull Market I Have Ever Seen

Money manager Peter Grandich has a message that our own Nigel Somerville will be delighted to hear. Peter discusses the potential for this gold bull market and why it’s likely extraordinary. He says that Central Banks are buying at record levels, and many of those buying are doing it for safety reasons. He says that you should not bet against the Fed and don’t bet against central banks when it comes to gold and hence mining shares have yet to reflect what is happening, and are, arguably, as cheap as they can get regarding the price of gold.
ARB
premium content

Argo Blockchain is uninvestable says broker Fiske

I explained why I expected Argo (ARB) to go bust during 2023 yesterday HERE after scallywag CEO Peter Wall jumped ship. I am not to the only bear in town. Jeremy Smith of broker Fiske does not hold back, opining:
GDR
premium content

Genedrive CEO engages in sordid BB ramping - bailout discounted placing ahoy

David Budd the, CEO of Genedrive plc (GDR) has been out ramping this week with an RNS that one of its devices has received a preliminarily recommendation for use in the NHS. Not only that but he’s been posting over on the LSE asylum to groom the posters over there:
SGZ
premium content

The BBC bums its readers with the fake news pump that got Scotgold’s bailout placing away

I wonder if BBC journalist David Henderson, Pravda’s business correspondent in the second world post industrial transgender friendly shithole that is Scotland, feels any guilt about losing folks stacks of cash by publishing fake news? Ahead of a ramptastic and wholly fictitious article about Scotgold (SGZ), an AIM listed company teetering on a financial precipice the shares traded at 44.5p. Then Henderson published as you can see HERE.
SYME
premium content

BREAKING EXPOSE: The fraud Supply@Me Capital: – a dubious loan between Alessandro Zamboni and Dominic White controlled companies

At Companies House company 1AF2 Limited is late filing its accounts for the period from incorporation on 7 May 2021 to 31 May 2022. 1AF2 Limited is a wholly owned subsidiary of The AvantGarde Group Spa (“TAG”), the entity through which Alessandro Zamboni the CEO of Supply (SYME) holds his shares in the company.
ICON
premium content

Share price at Iconic Labs still insane –- EHGOSF continues to dump shares and Ott bills £50,000 a month

Today EHGOSF announced its fourth conversion under its the £3 million facility to Iconic Labs (ICON):
Bearcast
premium content

Tom Winnifrith Main Bearcast: Is Love Hemp now in administration?

In today's main bearcast I look at Love Hemp (LIFE) or should that be (DEATH)? then at Microsaic (MSYS), Advanced Oncotherapy (AVO), Guild ESports (GILD, Argo Blockchain (ARB) and finally Afentra (AET) after today's dynamite dossier HERE
GFIN
premium content

Gfinity – I was correct to be very wary of previously-stated commercial agreement ‘delight’... now bailout equity raise discussions

Previously writing on company describing itself as a “leading esports solutions provider” Gfinity (GFIN), last month with the shares up to 0.545p I cautioned ‘commercial agreement ‘delight’. Attempted ramptastic?’. Now an intra-day (uh oh!) “Business update and financing” announcement.

AET
premium content

BREAKING SHOCKING DOSSIER: Is £62m AIM darling Afentra Investor Trying To Hide Corruption Allegations And Russia Connections?

I only ask the question of this company, beloved by private investors, and at 28.1p valued at £62 million. A detailed dossier published below begs some serious questions.
BATS
premium content

British American Tobacco – full year numbers, a total return Buy

As I write the shares of British American Tobacco (BATS) are down below a 3000p share price today, meaning year-to-date the cigarette and more name is down over 10%. And yet, back in the COVID-19 peak crisis and then investment excitement bounceback moments in 2021, the stock was back at 2500p. And we have not even discussed the over 7% dividend yield. What is going on at the multinational tobacco and other nicotine forms company?
Dead-Donkey
premium content

BREAKING: OvalX/ETX/Monecor shutting spreadbet/CFD operations across Europe

Clients of OvalX, formerly ETX Capital, have just received an email warning them that the business is being shut down. This is not just in the UK, the owner Monecor, is shutting operations across Europe.
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

Most Read in the Past Seven Days

That Was the Week that Was

 

ANP

Anpario – a recovery Buy?...

Thursday »

Cat_Fixing_Lightbulb

Bearcast issue update: all should be well

 

ORCP

Oracle Power: Cynical Foul

Time left: 23:41:10